Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts

吉西他滨 胰腺癌 癌症研究 癌症 生物 基因表达 基因 医学 生物信息学 遗传学
作者
Mariam M. Konaté,Julia Krushkal,Ming-Chung Li,Li Chen,Yuri Kotliarov,Alida Palmisano,Rini Pauly,Qian Xie,P. Mickey Williams,Lisa M. McShane,Yingdong Zhao
出处
期刊:Journal of Translational Medicine [BioMed Central]
卷期号:22 (1)
标识
DOI:10.1186/s12967-024-05528-6
摘要

Abstract Background With poor prognosis and high mortality, pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies. Standard of care therapies for PDAC have included gemcitabine for the past three decades, although resistance often develops within weeks of chemotherapy initiation through an array of possible mechanisms. Methods We reanalyzed publicly available RNA-seq gene expression profiles of 28 PDAC patient-derived xenograft (PDX) models before and after a 21-day gemcitabine treatment using our validated analysis pipeline to identify molecular markers of intrinsic and acquired resistance. Results Using normalized RNA-seq quantification measurements, we first identified oxidative phosphorylation and interferon alpha pathways as the two most enriched cancer hallmark gene sets in the baseline gene expression profile associated with intrinsic gemcitabine resistance and sensitivity, respectively. Furthermore, we discovered strong correlations between drug-induced expression changes in glycolysis and oxidative phosphorylation genes and response to gemcitabine, which suggests that these pathways may be associated with acquired gemcitabine resistance mechanisms. Thus, we developed prediction models using baseline gene expression profiles in those pathways and validated them in another dataset of 12 PDAC models from Novartis. We also developed prediction models based on drug-induced expression changes in genes from the Molecular Signatures Database (MSigDB)’s curated 50 cancer hallmark gene sets. Finally, pathogenic TP53 mutations correlated with treatment resistance. Conclusion Our results demonstrate that concurrent upregulation of both glycolysis and oxidative phosphorylation pathways occurs in vivo in PDAC PDXs following gemcitabine treatment and that pathogenic TP53 status had association with gemcitabine resistance in these models. Our findings may elucidate the molecular basis for gemcitabine resistance and provide insights for effective drug combination in PDAC chemotherapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
上官若男的应助被江江采纳,获得20
刚刚
1秒前
寒冷紫青的应助被孤独梦曼采纳,获得100
1秒前
菜黎明关注了科研通微信公众号
1秒前
2秒前
Icey发布了新的文献求助30
2秒前
优秀振家发布了新的文献求助10
2秒前
jungwoo123完成签到,获得积分10
3秒前
3秒前
完美世界的应助被甜蜜的水香采纳,获得10
3秒前
4秒前
4秒前
5秒前
webel发布了新的文献求助10
5秒前
文成完成签到,获得积分10
5秒前
elo完成签到,获得积分10
5秒前
科目三的应助被宝z采纳,获得10
6秒前
7秒前
丫丫发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
8秒前
8秒前
勤恳幻姬完成签到 ,获得积分10
8秒前
8秒前
8秒前
8秒前
8秒前
8秒前
8秒前
SSSDEFEFGG发布了新的文献求助10
9秒前
9秒前
呼呼哈哈完成签到 ,获得积分10
10秒前
11秒前
秀丽天川发布了新的文献求助10
11秒前
12秒前
Shauna完成签到,获得积分10
12秒前
13秒前
花九发布了新的文献求助10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817